SILVER SPRING, Md. & JACKSONVILLE, Fla.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, and its subsidiary Lung Bioengineering Inc. (LBE) announced that the 500th lung transplant utilizing LBE’s centralized ex vivo lung perfusion (EVLP) service was completed last month. These 500 transplants were the result of evaluating over 800 donated lungs using centralized EVLP since 2014. The 500th transplant was completed in Jacksonville at Mayo Clinic in F

LOUISVILLE, Ky.–(BUSINESS WIRE)–Two YesCare healthcare providers were honored recently at the second annual LMDC Awards Banquet, honoring excellence in service at the Louisville Metro Department of Corrections. The banquet was held September 7 at University of Louisville’s Alumni Hall. Behavioral Health Director Brittany Elkins was named Mental Health Staffer of the Year, and MAT Nurse Coordinator Stacy Wylie was named Medical Staffer of the Year. The employee-driven, staff-voted awards eveni

**Eli Lilly’s Alzheimer’s Drug Donanemab Rejected for NHS Use** Eli Lilly’s promising Alzheimer’s treatment, donanemab, has hit a roadblock with the UK’s National Health Service (NHS), which recently chose not to recommend its use. This decision places donanemab in an uncertain position within the UK healthcare system, despite its potential to address unmet needs in

Asahi Kasei Medical has launched the Planova FG1, a next─generation virus removal filter featuring higher flux for the manufacture of biotherapeutics, in October 2024.

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time. United Therapeutics will host a public webcast Wednesday, October 30, 2024, at 9:00 a.m. Eastern Time. The webcast will be accessible via

In the top alliance by deal value, Prime Medicine and Bristol Myers Squibb teamed up to develop reagents for multiple next-generation, ex vivo CAR-T cell therapies in immunology and oncology. Prime

      

In April 2024 Citeline’s Scrip publication reviewed the internal and external R&D inputs of the top 15 companies by sales of prescription and over-the-counter drugs in 2023. This analysis reve

      

A new law in Germany fails to adequately address “flaws” in the pricing system that are discouraging companies from launching new, innovative products on the market. That is the warning from Alexander

      

NEW YORK–(BUSINESS WIRE)–Dante Omics, a trailblazer in genomics-driven artificial intelligence solutions, is proud to announce that its cutting-edge laboratory in Italy has been awarded the internationally recognized ISO 9001:2015 certification for “Provision of genomic Next Generation Sequencing, analysis and interpretation services.” The ISO9001 certification was issued to Dante Labs Srl. This achievement marks a significant step in the company’s commitment to maintaining the highest standa

NEW YORK–(BUSINESS WIRE)–Dante Omics, pioniere nelle soluzioni di intelligenza artificiale applicata alla genomica, è orgogliosa di annunciare che il suo laboratorio all’avanguardia in Italia ha ottenuto la certificazione internazionale ISO 9001:2015 per la "Fornitura di servizi di analisi e interpretazione del sequenziamento genomico di nuova generazione". La certificazione ISO 9001 è stata rilasciata a Dante Labs Srl. Questo traguardo segna un passo significativo nell’impegno dell’azienda a